2023-03-30T16:58:22+08:00 weekly 1.0 https://ar.prisysbiotech.com/ 2024-11-12T04:09:01+08:00 weekly 0.9 https://ar.prisysbiotech.com/hematological-disease-research 2023-03-31T15:57:47+08:00 weekly 0.9 https://ar.prisysbiotech.com/co-develop 2024-11-12T04:09:02+08:00 weekly 0.9 https://ar.prisysbiotech.com/metabolic-syndromes-research 2024-11-12T04:09:02+08:00 weekly 0.9 https://ar.prisysbiotech.com/respiratory-disease-research 2024-11-12T04:09:04+08:00 weekly 0.9 https://ar.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-12T04:09:03+08:00 weekly 0.9 https://ar.prisysbiotech.com/ophthalmic-disease-research 2024-11-12T04:09:12+08:00 weekly 0.9 https://ar.prisysbiotech.com/inflammation-immunology-disorders 2024-11-12T04:45:32+08:00 weekly 0.9 https://ar.prisysbiotech.com/animal-welfare 2024-11-12T04:08:50+08:00 weekly 0.9 https://ar.prisysbiotech.com/translational-research-center 2024-11-12T04:08:49+08:00 weekly 0.9 https://ar.prisysbiotech.com/download 2024-09-29T14:23:03+08:00 weekly 0.9 https://ar.prisysbiotech.com/fibrosis 2024-09-29T14:45:25+08:00 weekly 0.9 https://ar.prisysbiotech.com/nephrology 2024-11-12T04:08:50+08:00 weekly 0.9 https://ar.prisysbiotech.com/about-us 2024-11-12T04:08:49+08:00 weekly 0.9 https://ar.prisysbiotech.com/contact-us 2023-03-31T15:57:45+08:00 weekly 0.9 https://ar.prisysbiotech.com/newslist-1 2024-11-12T04:08:48+08:00 weekly 0.9 https://ar.prisysbiotech.com/products 2026-02-07T02:37:28+08:00 weekly 0.9 https://ar.prisysbiotech.com/blog/ 2023-03-31T15:36:36+08:00 weekly 0.9 https://ar.prisysbiotech.com/translation-research/ 2023-03-31T15:36:36+08:00 weekly 0.9 https://ar.prisysbiotech.com/safety-evaluation/ 2023-03-31T15:36:36+08:00 weekly 0.9 https://ar.prisysbiotech.com/biosafety-research/ 2023-03-31T15:36:36+08:00 weekly 1.0 https://ar.prisysbiotech.com/nhp-pharmacology/ 2023-03-31T15:57:36+08:00 weekly 0.9 https://ar.prisysbiotech.com/pk-pd-adme/ 2024-04-11T07:16:46+08:00 weekly 0.9 https://ar.prisysbiotech.com/clearpoint/ 2023-03-31T15:57:37+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2023-03-31T15:57:40+08:00 weekly 0.8 https://ar.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2023-03-31T15:57:40+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2024-11-12T04:08:56+08:00 weekly 0.8 https://ar.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2024-11-12T04:08:47+08:00 weekly 0.8 https://ar.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2024-11-12T04:09:30+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-03-31T15:57:41+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-03-31T15:57:37+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2023-03-31T15:57:38+08:00 weekly 0.8 https://ar.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-12T04:08:49+08:00 weekly 0.8 https://ar.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-12T04:08:51+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-12T04:08:47+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-12T04:08:50+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-11-12T04:08:46+08:00 weekly 0.8 https://ar.prisysbiotech.com/translation-research/nhpresources.html 2024-11-12T04:08:50+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2024-11-12T04:08:53+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2023-03-31T15:57:39+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2024-11-12T04:09:00+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-03-31T15:57:44+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ar.prisysbiotech.com/translation-research/translational-studies.html 2024-11-12T04:08:46+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-31T15:57:46+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2023-03-31T15:57:44+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-12T04:08:56+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2023-03-31T15:57:40+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-03-31T15:57:42+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2024-11-12T04:08:51+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-12T04:08:47+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2024-11-12T04:08:48+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2023-03-31T15:57:41+08:00 weekly 0.8 https://ar.prisysbiotech.com/safety-evaluation/toxicology.html 2023-03-31T15:57:43+08:00 weekly 0.8 https://ar.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-12T04:09:02+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2024-11-12T04:08:47+08:00 weekly 0.8 https://ar.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2024-11-12T04:08:48+08:00 weekly 0.8 https://ar.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ar.prisysbiotech.com/pk-pd-adme/adme.html 2023-03-31T16:31:12+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2024-11-12T04:08:53+08:00 weekly 0.8 https://ar.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-12T04:09:10+08:00 weekly 0.8 https://ar.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-12T04:08:54+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-12T04:09:06+08:00 weekly 0.8 https://ar.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-26T14:06:26+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-26T14:06:29+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-26T14:06:30+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-26T14:06:30+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-11-12T04:08:52+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-26T14:06:31+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-09-26T14:06:36+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-12-08T09:19:47+08:00 weekly 0.8 https://ar.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-08T23:16:32+08:00 weekly 0.8 https://ar.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-04-01T23:08:44+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-04-01T23:08:46+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-07-13T19:45:32+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-13T19:45:38+08:00 weekly 0.8 https://ar.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-20T01:55:45+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-14T02:25:35+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T08:32:36+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-25T01:15:17+08:00 weekly 0.8 https://ar.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-09-30T07:56:44+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T16:06:33+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T19:25:51+08:00 weekly 0.8 https://ar.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2023-03-31T15:36:36+08:00 weekly 0.9 https://ar.prisysbiotech.com/newslist-713823-1 2023-03-31T15:36:36+08:00 weekly 0.9 https://ar.prisysbiotech.com/newslist-713824-1 2024-07-29T16:28:02+08:00 weekly 0.9 https://ar.prisysbiotech.com/newslist-818678-1 2023-03-31T15:57:36+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/meetprisys-sot2023-66097244.html 2023-03-31T15:57:39+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-sot2023-66097245.html 2023-03-31T15:57:38+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/gene-therapy-nhp-model-66097246.html 2023-03-31T15:57:37+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66097247.html 2023-03-31T15:57:35+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66097248.html 2023-03-31T15:57:43+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66097249.html 2023-03-31T15:57:40+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66097250.html 2023-03-31T15:57:39+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66097256.html 2023-03-31T15:57:44+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66097261.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66273398.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/gene-therapy-toxicology-66273399.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/world-parkinsons-disease-day-67515783.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67515784.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67515785.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67515786.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67515787.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67515788.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67515790.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67515791.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68104432.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68104434.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68104436.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68104437.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68306170.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69003836.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69003837.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69004126.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69004655.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69006894.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69008524.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309357.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309371.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309400.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309402.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69654228.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69659300.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70955738.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/0-70955740.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70955741.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70955742.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70955744.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70955745.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321573.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321574.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321575.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321576.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321577.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72676473.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73001253.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73536500.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73536501.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74140112.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74654790.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74789256.html 2024-11-12T04:08:44+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75163407.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75163408.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76174242.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77052906.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77703144.html 2024-11-12T04:08:44+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77703160.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nhp-asthma-model-79185836.html 2024-11-12T04:08:53+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79185837.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79185838.html 2024-11-12T04:08:44+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79185839.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79185840.html 2024-11-12T04:45:37+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410614.html 2024-11-12T04:08:45+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410616.html 2024-11-12T04:08:50+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410618.html 2024-11-12T04:08:48+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pk-strategies-of-pdc-79527158.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79527159.html 2024-11-12T04:08:40+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79527160.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79527161.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79527162.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79527164.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79527166.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79527167.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79527168.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79527169.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79527170.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79527171.html 2024-11-12T04:45:36+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79527172.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79527173.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79527174.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79527175.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79527176.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79527177.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79527178.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79527179.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79527182.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79527183.html 2024-11-12T04:08:39+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79527184.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79527185.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79527186.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79527187.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79527189.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79527190.html 2024-11-12T04:08:42+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79527193.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79527194.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527195.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79527196.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/significance-principles-and-requirements-of-79527197.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79527198.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79527200.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79527201.html 2024-11-12T04:08:43+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79527202.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79527203.html 2024-11-12T04:08:41+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/mrna-based-therapies-past-79527204.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/mrna-based-therapies-present-79527205.html 2024-11-12T04:08:47+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79527206.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79527207.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79527208.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79527209.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527907.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79527911.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79527913.html 2024-08-07T08:44:34+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656478.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81120442.html 2024-11-12T04:08:44+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/convection-enhanced-delivery-81120443.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/human-disease-animal-models-81120444.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/china-experimental-monkey-industry-81120445.html 2024-11-12T04:45:33+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81120446.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/animal-models-of-human-diseases-81120447.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81120448.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81120449.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81120450.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81120451.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81120453.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/compartment-pk-model-81120454.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81120456.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82340532.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82798574.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82798575.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82798576.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82798577.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82798579.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82798580.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82798586.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82798588.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82798595.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83033953.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83035117.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83040123.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83995459.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83995460.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83995462.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83995464.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83995469.html 2025-01-18T22:54:05+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83995471.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83995487.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83995504.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83997811.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243900884460544.html 2025-02-27T00:48:23+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243901158024192.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295476548150272.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295476611785728.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295476647371776.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295476655023104.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/animal-models-for-womens-health-17295476688479232.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295476695917568.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295476717462528.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/membranous-nephropathy-model-17295476723786752.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295476797989888.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295476822205440.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295476836295680.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295476847387648.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17295476905780224.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295476921410560.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295477002560512.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295477019567104.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295477037622272.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17299244973646848.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374221109912576.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374221195846656.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374221209756672.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374221226861568.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374221227598848.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374221228008448.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374221229990912.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374221283419136.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374221498393600.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374221545497600.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374221626598400.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374269854901248.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17441081472934912.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17441081482798080.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17441081546597376.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/key-considerations-for-dosing-volume-17441081654977536.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17441081659302912.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17441081682060288.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17441081702949888.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17441081731146752.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17441081753592832.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17441081832596480.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17441081885713408.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17441113261073408.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17493821351830528.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17493821361513472.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17493821426050048.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17493821585597440.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17493822186726400.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nhp-copd-model-17493822430946304.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/the-importance-of-administration-volume-17529240547402752.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/brain-targeted-drug-delivery-17529240579318784.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17529240611988480.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17529240730444800.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17529240785265664.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17529240799896576.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17529240830092288.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17538073906930688.html 2025-09-30T07:57:04+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17552190933066752.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625024735634432.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625024771613696.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625024824845312.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625024856777728.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625024895525888.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625024929702912.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625024952493056.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nhp-renal-biopsy-17625025019618304.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625025154606080.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625063040721920.html 2026-04-08T02:10:20+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625101280207872.html 2025-12-25T16:06:33+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674428342838272.html 2025-12-25T16:06:34+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674428354126848.html 2025-12-25T16:06:35+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674428413879296.html 2025-12-25T16:06:39+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674428421088256.html 2025-12-25T16:06:40+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674428462261248.html 2025-12-25T16:06:47+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674428474582016.html 2025-12-25T16:06:44+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674428484019200.html 2025-12-25T16:06:39+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674428500435968.html 2025-12-25T16:06:50+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674428531172352.html 2026-01-29T19:25:24+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724160371057664.html 2026-01-29T19:25:32+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724160390964224.html 2026-01-29T19:25:39+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724160398976000.html 2026-01-29T19:25:29+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724160431006720.html 2026-01-29T19:25:33+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724160457663488.html 2026-01-29T19:25:32+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724160460596224.html 2026-01-29T19:25:33+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724160512664576.html 2026-01-29T19:25:34+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724160842179584.html 2026-01-29T19:25:32+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724160918627328.html 2026-01-29T19:25:39+08:00 weekly 0.8 https://ar.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724160976102400.html 2026-02-06T06:16:55+08:00 weekly 0.8 https://ar.prisysbiotech.com/blog/how-do-nhp-preclinical-studies-help-in-the-development-of-geriatric-drugs-2844578.html 2026-02-12T04:51:27+08:00 weekly 0.8 https://ar.prisysbiotech.com/blog/how-are-nhps-selected-for-a-study-2921463.html 2026-02-27T06:19:51+08:00 weekly 0.8 https://ar.prisysbiotech.com/blog/what-are-the-advantages-of-using-an-nhp-cro-3016066.html 2026-03-03T06:29:07+08:00 weekly 0.8 https://ar.prisysbiotech.com/blog/what-is-the-pharmacokinetic-profile-of-inhaled-drugs-3053038.html 2026-03-10T06:10:54+08:00 weekly 0.8 https://ar.prisysbiotech.com/blog/how-do-pd-drugs-influence-the-immune-cells-in-the-brain-in-pharmacology-3122306.html 2026-03-24T05:34:31+08:00 weekly 0.8 https://ar.prisysbiotech.com/blog/how-to-measure-the-infarct-volume-in-the-mcao-nhp-model-3321686.html